Ongoing Studies
These methods help maximize outcomes across any discipline requiring complex medical decision making, including surgery, critical care, emergency medicine, orthopedics, transplant and oncology.
Tissue and Data Acquisition Protocol (TDAP): A standardized method for collecting clinical data and biological specimens from properly identified patients and healthy volunteers.
Timing of Debridement and Closure (WounDX): A validated CDST is designed to guide the timing of wound closure in traumatic wounds as well as to establish criteria from both the number and frequency of wound debridement, on a wound specific basis.
Invasive Fungal Infections (IFI): Developing predictive models using SC2i’s technology to diagnose invasive fungal infections, devastating infections, early and institute treatment at an accelerated pace.
Massive Transfusion Protocol: A smart phone application created to allow the accurate prediction of massive transfusion based on a sophisticated statistical model created using admission variables readily available to the clinician at the bedside.
Damage Control Laparotomy – Open Abdomen: SC2i will conduct a prospective observational trial to define biomarkers as objective criteria that will be used to develop a CDST, for this purpose.
Traumatic Brain Injury (TBI): Future development of an accurate CDST to assist clinicians in understanding immunologic implications with a mechanistic focus directed towards clinically translatable therapeutic manipulations.
Decompensation (Decomp): The Physiologic Decompensation project will provide real-time analytics to create situation awareness to enhance care. The general intent of this project is to accelerate individualized treatments and provide rapid decision support based on the early detection of physiologic decompensation with the overall tripartite goal of better health, better care and lower costs for both military and civilian populations.